Humana Inc: Form 10-Q for the period ended Jun 30, 2016
Filed with the SEC on Aug 3, 2016 and accepted by EDGAR at Aug 3, 2016, 08:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-04-01 to 2016-06-30 | $14.01bn | us-gaap:Revenues |
| Revenue | 6 months2016-01-01 to 2016-06-30 | $27.81bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2016-04-01 to 2016-06-30 | $1.73bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2016-01-01 to 2016-06-30 | $3.49bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-04-01 to 2016-06-30 | $683.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-01-01 to 2016-06-30 | $1.23bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-04-01 to 2016-06-30 | $47.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2016-01-01 to 2016-06-30 | $94.0m | us-gaap:InterestExpense |
| Income tax | 3 months2016-04-01 to 2016-06-30 | $325.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-01-01 to 2016-06-30 | $571.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-04-01 to 2016-06-30 | $311.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-01-01 to 2016-06-30 | $565.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-04-01 to 2016-06-30 | $2.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-06-30 | $3.75 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-01 to 2016-06-30 | $2.08 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-06-30 | $3.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-04-01 to 2016-06-30 | 150,806,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-01-01 to 2016-06-30 | 150,851,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2016-01-01 to 2016-06-30 | $206.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2016-01-01 to 2016-06-30 | $256.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2016-01-01 to 2016-06-30 | $90.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2016-01-01 to 2016-06-30 | $73.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-06-30 | $2.43bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $17.74bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $27.24bn | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $9.93bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-06-30 | $16.36bn | us-gaap:Liabilities |
| Long-term debt | At period end2016-06-30 | $3.79bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2016-06-30 | $300.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2016-06-30 | $10.87bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2016-06-30 | 149,067,340 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-16-000169. Last ingested by Listed: Nov 6, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.